JAMA Network Home
Sign In
Comment & Response

Fluids for Immune Checkpoint Inhibitor Diabetic Ketoacidosis—Reply

JAMA Oncology 10.1001/jamaoncol.2026.1589

June 04, 2026 at 11:00 AM EDT

Read the full article

Corresponding Author: Elad Sharon, MD, MPH, Department of Medicine, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215 (elad_sharon@dfci.harvard.edu)

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2026.1589?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=060426

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks